191 related articles for article (PubMed ID: 23091827)
1. Faculty of Consulting Physicians of South Africa (FCPSA): saving brain with dabigatran.
Aalbers J; Hardy G
Cardiovasc J Afr; 2012 Jul; 23(6):350-1. PubMed ID: 23091827
[No Abstract] [Full Text] [Related]
2. Dabigatran for stroke prevention in all patients with atrial fibrillation?
Hunchuck JE; Lake JD
Pharmacotherapy; 2011 Aug; 31(8):725-8. PubMed ID: 21923597
[No Abstract] [Full Text] [Related]
3. Dabigatran efficacy-safety assessment for stroke prevention in patients with atrial fibrillation.
Eikelboom JW; Quinlan DJ; Connolly SJ; Hart RG; Yusuf S
J Thromb Haemost; 2012 May; 10(5):966-8. PubMed ID: 22360879
[No Abstract] [Full Text] [Related]
4. [New anticoagulants in patients with atrial fibrillation].
Diener HC; Weber R
MMW Fortschr Med; 2013 May; 155(8):55-6, 58. PubMed ID: 24437140
[No Abstract] [Full Text] [Related]
5. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
Chevalier J; Delaitre O; Hammès F; de Pouvourville G
Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
[TBL] [Abstract][Full Text] [Related]
6. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
7. Higher persistence in newly diagnosed nonvalvular atrial fibrillation patients treated with dabigatran versus warfarin.
Zalesak M; Siu K; Francis K; Yu C; Alvrtsyan H; Rao Y; Walker D; Sander S; Miyasato G; Matchar D; Sanchez H
Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):567-74. PubMed ID: 23922182
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation.
Shah SV; Gage BF
Circulation; 2011 Jun; 123(22):2562-70. PubMed ID: 21606397
[TBL] [Abstract][Full Text] [Related]
9. Dabigatran and warfarin for secondary prevention of stroke in atrial fibrillation patients: a nationwide cohort study.
Larsen TB; Rasmussen LH; Gorst-Rasmussen A; Skjøth F; Lane DA; Lip GY
Am J Med; 2014 Dec; 127(12):1172-8.e5. PubMed ID: 25193361
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Kamel H; Johnston SC; Easton JD; Kim AS
Stroke; 2012 Mar; 43(3):881-3. PubMed ID: 22308255
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation in 2010: advances in treatment and management.
Connolly SJ
Nat Rev Cardiol; 2011 Feb; 8(2):67-8. PubMed ID: 21270842
[TBL] [Abstract][Full Text] [Related]
13. [Dabigatran in prevention of stroke in atrial fibrillation: three years of clinical application].
Zotova IV; Zateĭshchikov DA
Kardiologiia; 2014; 54(2):79-85. PubMed ID: 24888206
[No Abstract] [Full Text] [Related]
14. [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
Lewalter T
MMW Fortschr Med; 2012 Mar; 154(5):50-2, 54. PubMed ID: 22624265
[No Abstract] [Full Text] [Related]
15. Endovascular thrombectomy for acute ischemic stroke patients anticoagulated with dabigatran.
Müller P; Topakian R; Sonnberger M; Nußbaumer K; Windpessl M; Eder V; Nesser HJ; Trenkler J; Haring HP
Clin Neurol Neurosurg; 2013 Oct; 115(10):2257-9. PubMed ID: 23921437
[No Abstract] [Full Text] [Related]
16. Balancing the benefits and risks of 2 doses of dabigatran compared with warfarin in atrial fibrillation.
Eikelboom JW; Connolly SJ; Hart RG; Wallentin L; Reilly P; Oldgren J; Yang S; Yusuf S
J Am Coll Cardiol; 2013 Sep; 62(10):900-8. PubMed ID: 23770182
[TBL] [Abstract][Full Text] [Related]
17. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
[TBL] [Abstract][Full Text] [Related]
19. Patterns of oral anticoagulants use in atrial fibrillation.
Brais C; Larochelle J; Turgeon M; Tousignant A; Blais L; Perreault S; Farand P; Letemplier G; Beauchesne M
J Popul Ther Clin Pharmacol; 2015; 22(1):e90-5. PubMed ID: 25715385
[TBL] [Abstract][Full Text] [Related]
20. [Dabigatran eteksilat new anticoagulant for the prevention of stroke in patients with atrial fibrillation without valvular lesions].
Panchenko EP
Kardiologiia; 2011; 51(11):83-90. PubMed ID: 22117775
[No Abstract] [Full Text] [Related]
[Next] [New Search]
